|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2100051275 |
|
最近更新日期: Date of Last Refreshed on: |
2021-09-17 22:29:44 |
|
注册时间: Date of Registration: |
2021-09-17 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
该研究尚未获得伦理委员会批准,请于批准后再开始纳入参试者,并与我们联系上传批件。 膝骨关节炎摆腿疗法(KOAPT)治疗膝关节骨性关节炎临床研究 |
|
Public title: |
Clinical study of Knee Osteoarthritis Pendulum Therapy in the treatment of Knee Osteoarthritis |
|
注册题目简写: |
膝骨关节炎摆腿疗法 |
|
English Acronym: |
Knee Osteoarthritis Pendulum Therapy |
|
研究课题的正式科学名称: |
膝骨关节炎摆腿疗法(KOAPT)治疗膝关节骨性关节炎的前瞻性随机对照研究 |
|
Scientific title: |
A prospective randomized controlled study of knee osteoarthritis treated with Knee Osteoarthritis Pendulum Therapy(KOAPT) |
|
研究课题代号(代码): Study subject ID: |
KOAPT-001 |
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
宋九宏 |
研究负责人: |
黄丽霞 |
|
Applicant: |
Jiuhong Song |
Study leader: |
Huang Lixia |
|
申请注册联系人电话: Applicant telephone: |
13207117799 |
研究负责人电话:
Study leader's |
18086001311 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
hlxgw2011@163.com |
研究负责人电子邮件: Study leader's E-mail: |
yhzy2001@qq.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
武汉肤尔医用科技有限公司 |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
江汉大学 https://www.jhun.edu.cn/ |
|
申请注册联系人通讯地址: |
湖北省武汉市江汉区解放大道686号世贸大厦写字楼31楼 |
研究负责人通讯地址: |
湖北省武汉市武汉经济开发区三角湖路8号 |
|
Applicant address: |
31 / F, office building, world trade building, No. 686, Jiefang Avenue, Jianghan District, Wuhan City, Hubei Province |
Study leader's address: |
No. 8, Sanjiaohu Road, Wuhan Economic Development Zone, Wuhan City, Hubei Province |
|
申请注册联系人邮政编码: Applicant postcode: |
430030 |
研究负责人邮政编码: Study leader's postcode: |
430056 |
|
申请人所在单位: |
武汉肤尔医用科技有限公司 |
||
|
Applicant's institution: |
Wuhan Fuer Medical Technology Co., Ltd |
||
|
研究负责人所在单位: |
江汉大学 |
||
|
Affiliation of the Leader: |
Jianghan University |
||
|
是否获伦理委员会批准: |
否 |
||
|
Approved by ethic committee: |
No |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
伦理委员会批件附件: Approved file of Ethical Committee: |
||
|
批准本研究的伦理委员会名称: |
|
||
|
Name of the ethic committee: |
|
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2013-08-26 00:00:00 | ||
|
伦理委员会联系人: |
|
||
|
Contact Name of the ethic committee: |
|
||
|
伦理委员会联系地址: |
|
||
|
Contact Address of the ethic committee: |
|
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
||
|
研究实施负责(组长)单位: |
中国人民解放军中部战区总医院 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Primary sponsor: |
Wuhan Fuer Medical Technology Co., Ltd |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
湖北省武汉市武珞路627号 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Primary sponsor's address: |
31 / F, office building, world trade building, No. 686, Jiefang Avenue, Jianghan District, Wuhan City, Hubei Province |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
经费或物资来源: |
武汉肤尔医用科技有限公司 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Source(s) of funding: |
Wuhan Fuer Medical Technology Co., Ltd |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
研究疾病: |
膝关节骨性关节炎 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Target disease: |
Knee Osteoarthritis |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
研究疾病代码: |
KOA |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Target disease code: |
KOA |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
研究所处阶段: |
探索性研究/预试验 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Study phase: |
0 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
研究设计: |
随机平行对照 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Study design: |
Parallel |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
研究目的: |
本研究旨在探讨膝骨关节炎摆动疗法治疗膝关节骨性关节炎的有效性、可接受性、安全 性和潜在影响的程度 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Objectives of Study: |
The purpose of this study is to investigate the usability, acceptability, safety, feasibility and extent of the potential effect of Swing leg therapy (Knee Osteoarthritis Pendulum Therapy, KOAPT) on knee osteoarthritis outcomes in people with KOA . |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
纳入标准: |
纳入标准:必须满足以下所有标准: |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Inclusion criteria |
Inclusion criteria: All the following criteria must be met : |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
排除标准: |
如有下列情况之一,将不被选中: |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Exclusion criteria: |
Exclusion criteria: If there is one of the following conditions, it will not be selected : |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2021-10-01 00:00:00至 To 2022-07-31 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2021-10-01 00:00:00 至 To 2022-01-31 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
实验室人员将使用Microsoft Excel中的计算机程序生成随机数表。编码将被密封在不透明的,连续编号的信封里,由一位独立的管理人员保存。信封将是由管理者按顺序打开的,然后通过电子邮件向相关的治疗医师告知分组分配情况,然后参与者才出席他或她的首次预约。在整个试验过程中,将进行评估的研究人员将对分组不可见。统计学家将对随机化数字表的遵守情况进行监控。 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
The laboratory staff will use a computer program in Microsoft Excel to generate a random number table. The code will be sealed in an opaque, consecutively numbered envelope and kept by an independent manager. The envelope will be opened by the manager in order, and then the relevan |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
不公开/Private |
|
盲法: |
收集基线数据后分层随机分配受试者。评估者将不知道分组。受试者和医务人员知晓。 |
|
Blinding: |
After collecting baseline data, subjects are randomly assigned in stratification. The evaluator will not know the grouping. Subject and medical staff knew. |
|
是否共享原始数据: IPD sharing |
是Yes |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
公开时间:研究结果发表6个月内;公开方式:MESMAN 平台;共享方式:向研究者索取 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
Publication time: within 6 months after the publication of the research results; Disclosure mode: mesman platform; The sharing method is: ask researchers for |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
病例报告表和EDC采集和管理数据 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
Case report form and EDC collect and manage data |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
暂未确定/Not yet |